【Press seminar】 The Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, in collaboration with the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, has succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificality in treating orthotopically transplanted mice with glioblastoma (GBM), A press seminar was held.
This research result was published in "Nature Biomedical Engineering"